Belgium's DNAVision Buys Illumina HiScanSQ to Upgrade Array, Sequencing Services

DNAVision CEO Jean-Pol Detiffe said this week that the company will use the HiScanSQ for its pharmaceutical and medical research customers' ongoing genome-wide association projects.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories